Inhibition of Lp(a)-induced functional impairment of endothelial cells and endothelial progenitor cells by hepatocyte growth factor

Biochemical and Biophysical Research Communications

Volumn 423, Issue 1, 2012, Pages 79-84

  Iwabayashi, Masaaki ^a   Taniyama, Yoshiaki ^a   Sanada, Fumihiro ^a   Azuma, Junya ^a   Iekushi, Kazuma ^a   Okayama, Keita ^a   Chatterjee, Amarnath ^a   Rakugi, Hiromi ^a   Morishita, Ryuichi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

EPC; HGF; Lp(a); PAD; Senescence

Indexed keywords

BETA GALACTOSIDASE; CD31 ANTIGEN; HYDROETHIDINE; LIPOPROTEIN A; MATRIGEL; PLASMID DNA; PROTEIN P21; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SCATTER FACTOR;

ANGIOGENESIS; AORTA; ARTICLE; ATHEROSCLEROSIS; CAPILLARY; CELL AGING; CELL CULTURE; CELL FUNCTION; CELL LINEAGE; CONTROLLED STUDY; DNA TRANSFECTION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; ENZYME ACTIVITY; EX VIVO STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; LIMB ISCHEMIA; LIMB PERFUSION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION;

ANIMALS; ATHEROSCLEROSIS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HEPATOCYTE GROWTH FACTOR; HINDLIMB; HUMANS; ISCHEMIA; LIPOPROTEIN(A); MICE; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; STEM CELL TRANSPLANTATION; STEM CELLS; TUMOR SUPPRESSOR PROTEIN P53;

MUS MUSCULUS;

EID: 84862691570     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.05.086     Document Type: Article

References (33)

1. McLean J., Tomlinson J., Kuang W., Eaton D., Chen E., Fless G., Scanu A., Lawn R. CDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 1987, 330:132-137.
2. Eaton D.L., Fless G.M., Kohr W.J., McLean J.W., Xu Q.T., Miller C.G., Lawn R.M., Scanu A.M. Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. Proceedings of the National Academy of Sciences of the United States of America 1987, 84:3224-3228.
3. Biemond B.J., Friederich P.W., Koschinsky M.L., Levi M., Sangrar W., Xia J., Buller H.R., ten Cate J.W. Apolipoprotein(a) attenuates endogenous fibrinolysis in the rabbit jugular vein thrombosis model in vivo. Circulation 1997, 96:1612-1615.
4. Morishita R., Sakaki M., Yamamoto K., Iguchi S., Aoki M., Yamasaki K., Matsumoto K., Nakamura T., Lawn R., Ogihara T. Impairment of collateral formation in lipoprotein (a) transgenic mice. therapeutic angiogenesis induced by human hepatocyte growth factor gene. Circulation 2002, 105:1491.
5. Dieplinger B., Lingenhel A., Baumgartner N., Poelz W., Dieplinger H., Haltmayer M., Kronenberg F., Mueller T. Increased serum lipoprotein (a) concentrations and low molecular weight phenotypes of apolipoprotein (a) are associated with symptomatic peripheral arterial disease. Clinical Chemistry 2007, 53:1298.
6. Bostom A.G., Cupples L.A., Jenner J.L., Ordovas J.M., Seman L.J., Wilson P.W., Schaefer E.J., Castelli W.P. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA: Journal of the American Medical Association 1996, 276:544-548.
7. Jurgens G., Taddei-Peters W.C., Koltringer P., Petek W., Chen Q., Greilberger J., Macomber P.F., Butman B.T., Stead A.G., Ransom J.H. Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease. Stroke: A Journal of Cerebral Circulation 1995, 26:1841-1848.
8. Minamino T., Komuro I. Vascular cell senescence. contribution to atherosclerosis. Circulation Research 2007, 100:15.
9. Imanishi T., Hano T., Sawamura T., Nishio I. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clinical and Experimental Pharmacology and Physiology 2004, 31:407-413.
10. Maier J., Barenghi L., Bradamante S., Pagani F. Induction of human endothelial cell growth by mildly oxidized low density lipoprotein. Atherosclerosis 1996, 123:115-121.
11. Liu L., Wen T., Zheng X.Y., Yang D.G., Zhao S.P., Xu D.Y., Lü G.H. Remnant-like particles accelerate endothelial progenitor cells senescence and induce cellular dysfunction via an oxidative mechanism. Atherosclerosis 2009, 202:405-414.
12. Taniyama Y., Morishita R., Hiraoka K., Aoki M., Nakagami H., Yamasaki K., Matsumoto K., Nakamura T., Kaneda Y., Ogihara T. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetes. Circulation 2001, 104:2344.
13. Kalka C., Masuda H., Takahashi T., Kalka-Moll W., Silver M., Kearney M., Li T., Isner J., Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:3422.
14. Fan Y., Ye J., Shen F., Zhu Y., Yeghiazarians Y., Zhu W., Chen Y., Lawton M.T., Young W.L., Yang G.Y. Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 2008, 28:90-98.
15. Wu Y., Ip J.E., Huang J., Zhang L., Matsushita K., Liew C.C., Pratt R.E., Dzau V.J. Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circulation Research 2006, 99:315-322.
16. Dimmeler S., Aicher A., Vasa M., Mildner-Rihm C., Adler K., Tiemann M., Rutten H., Fichtlscherer S., Martin H., Zeiher A.M. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. The Journal of Clinical Investigation 2001, 108:391-397.
17. Nakagami F., Nakagami H., Osako M.K., Iwabayashi M., Taniyama Y., Doi T., Shimizu H., Shimamura M., Rakugi H., Morishita R. Estrogen attenuates vascular remodeling in Lp(a) transgenic mice. Atherosclerosis 2010, 211:41-47.
18. Yokoi T., Fukuo K., Yasuda O., Hotta M., Miyazaki J., Takemura Y., Kawamoto H., Ichijo H., Ogihara T. Apoptosis signal-regulating kinase 1 mediates cellular senescence induced by high glucose in endothelial cells. Diabetes 2006, 55:1660.
19. Szocs K., Lassegue B., Sorescu D., Hilenski L., Valppu L., Couse T., Wilcox J., Quinn M., Lambeth J., Griendling K. Upregulation of Nox-based NAD (P) H oxidases in restenosis after carotid injury. Arteriosclerosis, Thrombosis, and Vascular Biology 2002, 22:21.
20. Sanada F., Taniyama Y., Azuma J., Iekushi K., Dosaka N., Yokoi T., Koibuchi N., Kusunoki H., Aizawa Y., Morishita R. Hepatocyte growth factor, but not vascular endothelial growth factor, attenuates angiotensin II-induced endothelial progenitor cell senescence. Hypertension 2009, 53:77-82.
21. Tepper O., Galiano R., Capla J., Kalka C., Gagne P., Jacobowitz G., Levine J., Gurtner G. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002, 106:2781.
22. Iwaguro H., Yamaguchi J., Kalka C., Murasawa S., Masuda H., Hayashi S., Silver M., Li T., Isner J., Asahara T. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002, 105:732.
23. Hill J., Zalos G., Halcox J., Schenke W., Waclawiw M., Quyyumi A., Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. New England Journal of Medicine 2003, 348:593.
24. Asahara T., Kawamoto A., Masuda H. Concise review: Circulating endothelial progenitor cells for vascular medicine. Stem Cells 2011, 29:1650-1655.
25. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., Kearne M., Magner M., Isner J.M. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circulation Research 1999, 85:221-228.
26. Urbich C., Aicher A., Heeschen C., Dernbach E., Hofmann W.K., Zeiher A.M., Dimmeler S. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. Journal of Molecular and Cellular Cardiology 2005, 39:733-742.
27. Ii M., Nishimura H., Iwakura A., Wecker A., Eaton E., Asahara T., Losordo D.W. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via " imported" nitric oxide synthase activity. Circulation 2005, 111:1114-1120.
28. Shigematsu H., Yasuda K., Iwai T., Sasajima T., Ishimaru S., Ohashi Y., Yamaguchi T., Ogihara T., Morishita R. Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia. Gene Therapy 2010, 17:1152-1161.
29. Morishita R., Makino H., Aoki M., Hashiya N., Yamasaki K., Azuma J., Taniyama Y., Sawa Y., Kaneda Y., Ogihara T. Phase I/IIa clinical trial of therapeutic angiogenesis using hepatocyte growth factor gene transfer to treat critical limb ischemia. Arteriosclerosis, Thrombosis, and Vascular Biology 2011, 31:713-720.
30. Miyauchi H., Minamino T., Tateno K., Kunieda T., Toko H., Komuro I. Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway. The EMBO Journal 2004, 23:212.
31. Galle J., Schneider R., Heinloth A., Wanner C., Galle P., Conzelmann E., Dimmeler S., Heermeier K. Lp (a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: role of oxidative stress. Kidney International 1999, 55:1450-1461.
32. Greiber S., Kreusel M., Pavenstadt H., Schollmeyer P., Wanner C. Lipoprotein (a) induces glomerular superoxide anion production. Nephrology Dialysis Transplantation 1997, 12:1330.
33. Sanada F., Taniyama Y., Iekushi K., Azuma J., Okayama K., Kusunoki H., Koibuchi N., Doi T., Aizawa Y., Morishita R. Negative action of hepatocyte growth factor/c-Met system on angiotensin II signaling via ligand-dependent epithelial growth factor receptor degradation mechanism in vascular smooth muscle cells. Circulation Research 2009, 105:667-675.